反応式
[CH3:1][C:2]1[CH:11]=[CH:10][C:5]([C:6]([O:8]C)=O)=[CH:4][C:3]=1[N:12]1[CH:17]=[CH:16][N:15]=[C:14](OC2C=CC=CC=2)[C:13]1=[O:25].[CH3:26][S:27][C:28]1[CH:33]=[CH:32][CH:31]=[CH:30][C:29]=1[CH2:34][NH2:35].[CH:36]1([NH2:39])[CH2:38][CH2:37]1.C1([Mg]Br)CCCC1>O1CCCC1>[CH:36]1([NH:39][C:6](=[O:8])[C:5]2[CH:10]=[CH:11][C:2]([CH3:1])=[C:3]([N:12]3[CH:17]=[CH:16][N:15]=[C:14]([NH:35][CH2:34][C:29]4[CH:30]=[CH:31][CH:32]=[CH:33][C:28]=4[S:27][CH3:26])[C:13]3=[O:25])[CH:4]=2)[CH2:38][CH2:37]1参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
反応条件
- 温度
- 120 °C
実験手順
A mixture of 4-methyl-3-(2-oxo-3-phenoxy-2H-pyrazin-1-yl)-benzoic acid, methyl ester (Example 128a, 111 mg), 2-(methylthio)-benzenemethanamine (100 mg) and tetrahydrofuran (1 mL) was heated within a microwave for 5 h at 120° C. before being cooled to room temperature. Cyclopropylamine (0.2 mL) was added followed by addition of cyclopentylmagnesium bromide (2M in diethyl ether, 0.8 mL). The mixture was stirred for 10 min., quenched with sat. NH4Cl and extracted into ethyl acetate. The organic phase was concentrated in vacuo. Purification by preparative HPLC (Gemini column, 0.1% ammonia:acetonitrile eluent) afforded the title compound as a solid (39 mg).
後処理
- temperaturebefore being cooled to room temperature
- customquenched with sat. NH4Cl
- extractionextracted into ethyl acetate
- concentrationThe organic phase was concentrated in vacuo
- customPurification by preparative HPLC (Gemini column, 0.1% ammonia:acetonitrile eluent)
出典と根拠
- ORDレコード
- ord-c25f112a054e4f8a8e90ad4b9bef77e6
- 出典データセット
- uspto-grants-2014_11
- 特許番号
- US08889692B2
関連ノート
読み込み中…